CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...